Allergan Upgraded To Overweight Amid 'Overdone' Botox Fears At Morgan Stanley
November 29, 2017 at 08:25 AM EST
Morgan Stanley analyst David Risinger upgraded Allergan to Overweight from Equal Weight, saying that fears about a "better Botox" from Revance may be overdone.
